Patient satisfaction after switching from warfarin to apixaban in patients with nonvalvular atrial fibrillation: AGAIN study

PURPOSE: Patients treated with warfarin must adhere to frequent monitoring, dietary restrictions, and complicated dose adjustments. Apixaban, a direct factor Xa inhibitor, is an alternative to warfarin that may reduce patient burdens associated with warfarin therapy. However, there is limited eviden...

Descripción completa

Detalles Bibliográficos
Autores principales: Koretsune, Yukihiro, Ikeda, Takanori, Kozuma, Ken, Hirano, Teruyuki, Yasaka, Masahiro, Kida, Makoto, Chachin, Motohiko, Imura, Miki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735985/
https://www.ncbi.nlm.nih.gov/pubmed/29290682
http://dx.doi.org/10.2147/PPA.S152579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735985/
https://www.ncbi.nlm.nih.gov/pubmed/29290682
http://dx.doi.org/10.2147/PPA.S152579

Ejemplares similares